Correlation Between Inspira Technologies and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inspira Technologies and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inspira Technologies and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inspira Technologies Oxy and TC BioPharm plc, you can compare the effects of market volatilities on Inspira Technologies and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inspira Technologies with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inspira Technologies and TC BioPharm.

Diversification Opportunities for Inspira Technologies and TC BioPharm

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between Inspira and TCBPW is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Inspira Technologies Oxy and TC BioPharm plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm plc and Inspira Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inspira Technologies Oxy are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm plc has no effect on the direction of Inspira Technologies i.e., Inspira Technologies and TC BioPharm go up and down completely randomly.

Pair Corralation between Inspira Technologies and TC BioPharm

Assuming the 90 days horizon Inspira Technologies is expected to generate 6.47 times less return on investment than TC BioPharm. But when comparing it to its historical volatility, Inspira Technologies Oxy is 4.69 times less risky than TC BioPharm. It trades about 0.07 of its potential returns per unit of risk. TC BioPharm plc is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  16.00  in TC BioPharm plc on September 21, 2024 and sell it today you would lose (14.85) from holding TC BioPharm plc or give up 92.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy87.47%
ValuesDaily Returns

Inspira Technologies Oxy  vs.  TC BioPharm plc

 Performance 
       Timeline  
Inspira Technologies Oxy 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Inspira Technologies Oxy are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Inspira Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
TC BioPharm plc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in TC BioPharm plc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, TC BioPharm showed solid returns over the last few months and may actually be approaching a breakup point.

Inspira Technologies and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inspira Technologies and TC BioPharm

The main advantage of trading using opposite Inspira Technologies and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inspira Technologies position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Inspira Technologies Oxy and TC BioPharm plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Commodity Directory
Find actively traded commodities issued by global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum